Publications by authors named "Vipheaviny A Chea"

Claim this Profile
A
A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings.
Steven P Treon, Camille N Kotton, David J Park, Giorgia Moranzoni, Camilla K Lemvigh, Vipheaviny A Chea

Front Immunol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies.
Shanye Yin, Susan Klaeger, Vipheaviny A Chea, Isabel P Carulli, Suzanna Rachimi

Front Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma.
Patrick C Lee, Susan Klaeger, Phuong M Le, Keegan Korthauer, Jingwei Cheng, Vipheaviny A Chea

J Clin Invest· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.
Shira Weingarten-Gabbay, Susan Klaeger, Siranush Sarkizova, Leah R Pearlman, Da-Yuan Chen, Vipheaviny A Chea

Cell· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis